Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Alexion_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2011
|
| gptkbp:focus |
complement system therapeutics
|
| gptkbp:foundedIn |
gptkb:Cambridge,_Massachusetts,_United_States
2004 |
| https://www.w3.org/2000/01/rdf-schema#label |
Taligen Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
TA106
|
| gptkbp:status |
defunct
|
| gptkbp:website |
http://www.taligentherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Alta_Partners
|
| gptkbp:bfsLayer |
7
|